| The effect of ABO blood group and antibody class on the risk of COVID-19 infection and severity of clinical outcomes MA Almadhi, A Abdulrahman, A Alawadhi, AA Rabaan, S Atkin, ... Scientific reports 11 (1), 5745, 2021 | 65 | 2021 |
| Association between RT-PCR Ct values and COVID-19 new daily cases: a multicenter cross-sectional study A Abdulrahman, SI Mallah, A Alawadhi, S Perna, EM Janahi, ... Le Infezioni in Medicina 29 (3), 416, 2021 | 28 | 2021 |
| Comparison of SARS-COV-2 nasal antigen test to nasopharyngeal RT-PCR in mildly symptomatic patients A Abdulrahman, F Mustafa, AI AlAwadhi, Q Alansari, B AlAlawi, ... MedRxiv, 2020.11. 10.20228973, 2020 | 28 | 2020 |
| COVID-19 recovery patterns across alpha (B. 1.1. 7) and Delta (B. 1.617. 2) variants of SARS-CoV-2 N Kumar, S Quadri, AI AlAwadhi, M AlQahtani Frontiers in immunology 13, 812606, 2022 | 21 | 2022 |
| Safety and efficacy of COVID-19 prime-boost vaccinations: homologous BBIBP-CorV versus heterologous BNT162b2 boosters in BBIBP-CorV-primed individuals SI Mallah, A Alawadhi, J Jawad, P Wasif, B Alsaffar, E Alalawi, ... Vaccine 41 (12), 1925-1933, 2023 | 19 | 2023 |
| Quarantining arriving travelers in the era of COVID-19: balancing the risk and benefits a learning experience from Bahrain A Abdulrahman, M AlSabbagh, A AlAwadhi, JA Al-Tawfiq, AA Rabaan, ... Tropical diseases, travel medicine and vaccines 7 (1), 1, 2021 | 16 | 2021 |
| Evaluation of rapid antigen tests using nasal samples to diagnose SARS-CoV-2 in symptomatic patients M Alqahtani, A Abdulrahman, F Mustafa, AI Alawadhi, B Alalawi, SI Mallah Frontiers in Public Health 9, 728969, 2022 | 15 | 2022 |
| The efficacy and safety of hydroxychloroquine in patients with COVID-19: a multicenter national retrospective cohort A Abdulrahman, I AlSayed, M AlMadhi, J AlArayed, SJ Mohammed, ... Infectious diseases and therapy 10, 439-455, 2021 | 13 | 2021 |
| Safety and immunogenicity of COVID-19 BBIBP-CorV vaccine in children 3–12 years old K Greish, A Alawadhi, A Jaradat, A Almarabheh, M AlMadhi, J Jawad, ... Vaccines 10 (4), 586, 2022 | 9 | 2022 |
| Is glucose-6-phosphatase dehydrogenase deficiency associated with severe outcomes in hospitalized COVID-19 patients? N Kumar, AK AbdulRahman, AI AlAwadhi, M AlQahtani Scientific Reports 11 (1), 19213, 2021 | 8 | 2021 |
| Clinical and epidemiological characteristics of COVID-19 in a multi-National Cohort in the Middle East SI Mallah, A Abdulrahman, AI Alawadhi, MM AlQahtani Journal of epidemiology and global health 11 (2), 137, 2021 | 5 | 2021 |
| Diagnostic and monitoring utilities of saliva for SARS-CoV-2 AK AbdulRahman, A AlBastaki, A AlAwadhi, A Alwazaan, M AlQahtani medRxiv, 2020.12. 07.20244681, 2020 | 2 | 2020 |
| Comparing the Safety and Immunogenicity of homologous (Sputnik V) and heterologous (BNT162B2) COVID-19 prime-boost vaccination M AlMadhi, A AlAwadhi, N Stevenson, K Greish, J Jawad, A Alsayyad, ... MedRxiv, 2022.08. 24.22279160, 2022 | 1 | 2022 |
| The implications of religious event and holidays on the transmission of SARS-CoV2: the impact of behavioral changes on transmission A Abdulrahman, M AlMajthoob, AI AlAwadhi, MM AlQahtani medRxiv, 2020.10. 17.20214056, 2020 | 1 | 2020 |
| A Narrative Review of the Coronavirus Disease 2019 Response in the Kingdom of Bahrain M AlQahtani, JS Jawad, A AlAwadhi, BM Al Saffar, EF AlAlawi, ... Current Therapeutic Research 100, 100733, 2024 | | 2024 |
| The Efficacy and Safety of Hydroxychloroquine in Patients with COVID-19: A Multicenter National Retrospective Cohort AAIASM AlMadhi, JAASJM Aesha, K Sharif | | 2021 |
| Le Infezioni in Medicina, n. 3, 416-426, 2021 A Abdulrahman, SI Mallah, A Alawadhi, S Perna, EM Janahi, ... | | |
Manaf alqahtaniProfessor of Medicine在 rcsi-mub.com 的电子邮件经过验证
